Jushi Holdings (JUSHF) Other Non-Current Assets (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Other Non-Current Assets came in at $2.1 million in Q1 2026, up 10.39% year-on-year from $1.9 million in Q1 2025, and down 92.36% on a QoQ basis from $27.8 million in Q4 2025.
Jushi Holdings (JUSHF) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Other Non-Current Assets data on file, last reported at $2.1 million in Q1 2026.
- On a quarterly basis, Other Non-Current Assets rose 10.39% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 10.39% increase from a year earlier, with the FY2025 full-year figure at $27.8 million, up 1423.34% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $2.1 million, down from $27.8 million in the prior quarter.
- Over the last five years, Other Non-Current Assets for JUSHF reached as high as $37.3 million in Q2 2023 and fell as low as $625000.0 in Q2 2022.
- Historically, Other Non-Current Assets has averaged $10.8 million across 5 years, with a median of $2.2 million in 2023.
- Across the five-year window, Other Non-Current Assets jumped 5863.36% in 2023 and tumbled 94.23% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $28.2 million in 2022, then tumbled by 92.39% to $2.2 million in 2023, then dropped by 15.12% to $1.8 million in 2024, then jumped by 1423.34% to $27.8 million in 2025, then slumped by 92.36% to $2.1 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $2.1 million in Q1 2026, $27.8 million in Q4 2025, and $2.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.13 Mn |
| Dec 31, 2025 | 27.80 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 1.93 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Sep 30, 2024 | 2.15 Mn |
| Jun 30, 2024 | 2.15 Mn |
| Mar 31, 2024 | 30.32 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 37.27 Mn |
| Mar 31, 2023 | 950,000.00 |
| Dec 31, 2022 | 28.24 Mn |
| Sep 30, 2022 | 28.15 Mn |
| Jun 30, 2022 | 625,000.00 |
| Dec 31, 2021 | 525,000.00 |